STOCK TITAN

Quantum-Si Incorporated - QSI STOCK NEWS

Welcome to our dedicated page for Quantum-Si Incorporated news (Ticker: QSI), a resource for investors and traders seeking the latest updates and insights on Quantum-Si Incorporated stock.

Quantum-Si Incorporated (NASDAQ: QSI) drives innovation in proteomics through its revolutionary single-molecule detection platform. This dedicated news hub provides investors and researchers with timely updates on the company's advancements in next-generation protein sequencing technology.

Access authoritative updates including product developments, strategic partnerships, and financial disclosures. Our curated collection ensures efficient tracking of QSI's progress in creating integrated hardware-software solutions for biomolecular analysis.

Key coverage areas: platform innovations enhancing protein detection accuracy, research collaborations advancing life sciences, and operational milestones shaping the future of proteomics tools. All content is verified through primary sources to ensure reliability.

Bookmark this page for streamlined access to Quantum-Si's latest developments in transformative protein sequencing solutions. Check regularly for updates that matter to both scientific and investment communities.

Rhea-AI Summary

Quantum-Si (Nasdaq: QSI), The Protein Sequencing Company, has scheduled its first quarter 2025 financial results announcement for Thursday, May 15, 2025. The company will host a conference call and webcast at 4:30 PM ET on the same day, featuring President and CEO Jeff Hawkins and CFO Jeff Keyes, who will discuss the financial performance and provide a business update.

Interested participants can join via live webcast through the Investors section of Quantum-Si's website under Events and Presentations, or register for a personalized dial-in number to join the call. A replay of the webcast will be available after the event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences earnings
-
Rhea-AI Summary

Quantum-Si (Nasdaq: QSI) has begun shipping its latest benchtop protein sequencer, Platinum® Pro, designed to make Next-Gen Protein Sequencing™ more accessible globally. The new system builds upon the original Platinum model with enhanced features including:

  • An enlarged touchscreen with intuitive user interface
  • Flexible local or cloud-based data analysis options
  • Pro Mode for custom application development through a Technology Access Program

The system offers single-molecule precision protein analysis through an integrated workflow and is now available in over 30 countries through direct and channel partner networks. According to CEO Jeff Hawkins, Platinum Pro aims to advance proteomics research and enable new biomarker discoveries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.42%
Tags
none
-
Rhea-AI Summary

Quantum-Si (Nasdaq: QSI), The Protein Sequencing Company™, has announced its participation in an upcoming DNAnexus webinar focused on proteomics in multi-omics research. The virtual event, scheduled for March 25, 2025, at 8 a.m. PT/11 a.m. ET, will explore how integrating proteomics data with other omics datasets drives new discoveries in disease research, including cancer.

Featured speakers include Meredith Carpenter, PhD from Quantum-Si, Cindy Lawley, PhD from Olink, Thermo Fisher Scientific, and Theresa Wohlever from DNAnexus. The webinar will cover:

  • The growing impact of proteomics in multi-omics analysis
  • Applications for cancer and other disease research
  • Technologies and strategies for large-scale discovery and data analysis
  • Tools for orthogonal validation of proteins of interest
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.72%
Tags
conferences
Rhea-AI Summary

Quantum-Si (Nasdaq: QSI), The Protein Sequencing Company™, has announced its participation in an upcoming DNAnexus webinar focused on proteomics in multi-omics research. The virtual event, scheduled for March 25, 2025, at 8 a.m. PT/11 a.m. ET, will explore how integrating proteomics data with other omics datasets drives new discoveries in disease research, including cancer.

Key speakers include Meredith Carpenter, PhD from Quantum-Si, Cindy Lawley, PhD from Olink, Thermo Fisher Scientific, and Theresa Wohlever from DNAnexus. The webinar will cover:

  • The growing impact of proteomics in multi-omics analysis
  • Applications for cancer and other disease research
  • Technologies and strategies for large-scale discovery and data analysis
  • Tools for orthogonal validation of proteins of interest
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.32%
Tags
conferences
-
Rhea-AI Summary

Quantum-Si (Nasdaq: QSI) has announced new employee inducement grants approved by its Board's Compensation Committee. The company granted 20,833 restricted stock units (RSUs) to new employees under its 2023 Inducement Equity Incentive Plan, in accordance with Nasdaq Listing Rule 5635(c)(4).

The RSUs vesting schedule includes 25% vesting on March 20, 2026, with the remaining portion vesting in 12 equal quarterly installments thereafter. Vesting is contingent upon continued employment with Quantum-Si. These equity awards are specifically designed for new hires who were not previously employed by the company, serving as an inducement for joining Quantum-Si.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.3%
Tags
none
-
Rhea-AI Summary

Quantum-Si (QSI) reported strong Q4 and full year 2024 financial results, achieving its first quarterly revenue over $1 million. Q4 revenue reached $1.2 million with a 51% gross margin, while full-year 2024 revenue totaled $3.1 million, representing 183% year-over-year growth.

The company successfully raised over $86 million in capital between Q4 2024 and early 2025, extending its cash runway into H2 2027. Key developments include the launch of Platinum® Pro in January 2025, new v2 Library Preparation Kit, and Barcoding Kit in December 2024. QSI reported a Q4 net loss of $33.1 million and full-year net loss of $101.0 million.

With $209.6 million in cash and investments as of December 31, 2024, QSI expects significant revenue growth in 2025, supported by new commercial partnerships with Avantor and international distributors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.15%
Tags
Rhea-AI Summary

Quantum-Si (QSI) and several researchers will present new research and applications at the 2025 Advances in Genome Biology and Technology (AGBT) General Meeting from February 23-26th. The presentations will include three scientific posters showcasing Next-Generation Protein Sequencing (NGPS™) innovations:

1. Dr. Meredith Carpenter from Quantum-Si will present how NGPS detects protein-level changes and post-translational modifications

2. Dr. Gloria Sheynkman from University of Virginia will demonstrate the integration of long-read RNA sequencing with the Platinum™ benchtop instrument for single-molecule peptide sequencing

3. Dr. Winston Timp from Johns Hopkins University will showcase how NGPS enables direct peptide sequencing to identify protein partners, offering a cost-effective alternative to legacy technologies

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.52%
Tags
none
-
Rhea-AI Summary

Quantum-Si (Nasdaq: QSI) announces its participation at the US Human Proteome Organization's 2025 conference in Philadelphia, featuring advances in Next-Generation Protein Sequencing™ (NGPS™). The company is sponsoring a panel discussion titled 'Breaking Boundaries: How Next-Generation Protein Sequencing™ is Shaping the Future of Proteomics' on February 25.

The event will showcase research using Quantum-Si's Platinum® Pro benchtop instrument, including new protein barcoding and library preparation solutions. Notable researchers from Washington University, University of Illinois Chicago, and University of Michigan will discuss NGPS's impact on proteomics.

Four scientific posters will be presented, covering: tropomyosin isoform differentiation, reduced protein input requirements, peptide variant mixture measurement, and protein barcoding for multiplexed analysis.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.57%
Tags
none
-
Rhea-AI Summary

Quantum-Si (QSI) has announced it will release its fourth quarter and full year 2024 financial results on Monday, March 3, 2025. The company will host a conference call and webcast at 4:30 PM ET on the same day, featuring President and CEO Jeff Hawkins and CFO Jeff Keyes, who will discuss the financial results and provide a business update.

Interested participants can join via webcast through the Investors section of Quantum-Si's website under Events and Presentations, or register for a personalized dial-in number. A replay of the event will be available afterward.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.08%
Tags
conferences earnings
Rhea-AI Summary

Quantum-Si (Nasdaq: QSI) announces a new preprint from Northwestern University researchers demonstrating the combined use of their Next-Generation Protein Sequencing™ (NGPS™) technology and Individual Ion Mass Spectrometry (I2MS) for analyzing interleukin-6 (IL-6), a key immune regulator and therapeutic target.

The study reveals that NGPS provided single amino acid resolution for IL-6 peptide fragments critical to receptor binding and function, while I2MS enabled intact proteoform detection and localized modifications, including glycosylation. The combination of these technologies offers comprehensive coverage of IL-6's structural and functional diversity, potentially advancing therapeutic research in complex diseases like cancer and autoimmune disorders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4%
Tags
none
Quantum-Si Incorporated

Nasdaq:QSI

QSI Rankings

QSI Stock Data

212.45M
139.49M
14.83%
29.05%
9.65%
Medical Devices
Measuring & Controlling Devices, Nec
Link
United States
BRANFORD